Retrophin, Inc.

Member Since

  • 2019

Membership Category

  • Biopharmaceuticals/Pharmaceuticals

Contact Information

San Diego, CA 92130
United States


  • Retrophin is a biopharmaceutical company specializing in identifying, developing and delivering life-changing therapies to people living with rare disease. The Company’s approach centers on its pipeline featuring late-stage assets targeting rare diseases with significant unmet medical needs, including fosmetpantotenate for pantothenate kinase-associated neurodegeneration (PKAN), and sparsentan for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). Research in additional rare diseases is also underway, including a joint development arrangement evaluating the potential of CNSA-001 in phenylketonuria (PKU).

Number of Employees

  • 50 - 499